Free Trial

Stantec (STN) Financials

Stantec logo
$92.20 +1.24 (+1.36%)
Closing price 03:59 PM Eastern
Extended Trading
$92.40 +0.19 (+0.21%)
As of 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Stantec

Annual Income Statements for Stantec

This table shows Stantec's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
60 -2,971 35 150 134 157 183 240 251 350
Consolidated Net Income / (Loss)
97 77 35 150 134 157 183 240 251 350
Net Income / (Loss) Continuing Operations
60 -2,971 126 150 125 157 183 240 251 350
Total Pre-Tax Income
135 -2,971 126 150 125 206 183 309 323 459
Total Operating Income
122 -2,991 152 221 168 243 237 272 294 444
Total Gross Profit
1,247 -1,780 1,330 1,548 1,513 1,537 1,786 3,730 3,972 4,647
Total Revenue
3,191 21 3,139 3,677 3,725 3,586 4,227 4,801 5,107 5,850
Operating Revenue
3,191 21 3,139 3,677 3,725 3,586 4,227 4,801 5,107 5,850
Total Cost of Revenue
1,981 1,801 1,849 2,172 2,257 2,045 2,499 1,071 1,134 1,203
Operating Cost of Revenue
1,981 1,801 1,849 2,172 2,257 2,045 2,499 1,071 1,134 1,203
Total Operating Expenses
1,088 1,210 1,138 1,284 1,300 1,294 1,492 3,458 3,678 4,203
Selling, General & Admin Expense
994 1,119 1,054 1,105 1,061 1,114 1,288 1,489 1,588 1,792
Depreciation Expense
38 41 37 134 138 127 132 138 135 149
Amortization Expense
56 58 48 52 42 47 77 77 86 108
Other Operating Expenses / (Income)
0.15 -7.95 0.07 -8.48 -1.65 -13 -5.17 1,755 1,845 2,150
Impairment Charge
- - - 1.54 62 19 - 0.23 24 4.38
Total Other Income / (Expense), net
-25 19 -26 -71 -44 -37 -54 -32 -43 -95
Interest Expense
21 21 21 54 39 30 54 70 73 74
Other Income / (Expense), net
-3.50 -3.34 -4.98 -18 -5.02 -7.36 - 38 29 -20
Weighted Average Basic Shares Outstanding
1.22 0.00 111.86M 111.21M 111.01M 111.33M 110.81M 111.23M 114.07M 114.07M
Weighted Average Diluted Shares Outstanding
- 0.00 111.86M 111.21M 111.01M 111.33M 110.81M 111.23M 114.07M 114.07M
Weighted Average Basic & Diluted Shares Outstanding
- 0.00 111.86M 111.21M 111.01M 111.33M 110.81M 222.46M 228.13M 228.13M

Quarterly Income Statements for Stantec

No quarterly income statements for Stantec are available.


Annual Cash Flow Statements for Stantec

This table details how cash moves in and out of Stantec's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
3,226 23 3,172 3,773 261 -29 18 155 -86 124
Net Cash From Operating Activities
0.00 3,366 2.71 2.23 63 16 62 394 419 629
Net Cash From Continuing Operating Activities
0.00 3,366 2.71 2.23 63 16 62 323 323 565
Net Income / (Loss) Continuing Operations
0.00 0.00 0.00 0.00 0.00 0.00 0.00 240 251 350
Consolidated Net Income / (Loss)
- - - - - - - 240 251 350
Depreciation Expense
- - - - 45 42 42 138 135 149
Non-Cash Adjustments To Reconcile Net Income
- 3,589 2.71 2.23 28 -46 -90 62 74 88
Changes in Operating Assets and Liabilities, net
- 15 - - -51 -28 33 -117 -138 -21
Net Cash From Investing Activities
3,318 -47 3,200 3,803 0.00 0.00 0.00 -153 -420 -390
Net Cash From Continuing Investing Activities
3,318 -47 3,200 3,803 0.00 0.00 0.00 -153 -420 -390
Acquisitions
- - - - - - - -57 -385 -331
Purchase of Investments
- - - - - - - -160 -97 -120
Sale and/or Maturity of Investments
- - - - - - - 55 51 60
Other Investing Activities, net
3,318 - 3,200 3,803 - - - 9.17 11 1.68
Net Cash From Financing Activities
-92 -219 -31 -31 197 -45 -45 -83 -106 -102
Net Cash From Continuing Financing Activities
-92 -219 -31 -31 197 -45 -45 -30 -30 -50
Repayment of Debt
-93 0.00 -31 -31 -36 -45 -45 -439 35 -285
Payment of Dividends
0.60 44 - - - - - -64 -65 -74
Issuance of Debt
- 163 - 0.00 234 - 0.00 264 0.00 308

Quarterly Cash Flow Statements for Stantec

No quarterly cash flow statements for Stantec are available.


Annual Balance Sheets for Stantec

This table presents Stantec's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 1/1/2023 12/31/2023 12/31/2024 12/31/2025
Total Assets
3,189 3,086 2,938 3,515 3,440 4,090 3,946 4,368 4,831 5,803
Total Current Assets
1,178 1,278 1,198 1,218 1,227 1,303 1,432 1,721 1,770 2,035
Cash & Equivalents
157 197 136 172 227 152 110 267 159 290
Accounts Receivable
600 978 643 630 579 645 1,169 1,278 1,422 1,508
Prepaid Expenses
46 43 42 33 31 36 36 41 45 49
Current Deferred & Refundable Income Taxes
35 49 35 28 37 67 48 55 45 93
Plant, Property, & Equipment, net
159 -17 212 221 188 183 -36 -39 -46 -34
Plant, Property & Equipment, gross
159 -17 212 221 188 183 -36 -39 -46 -34
Total Noncurrent Assets
1,852 1,819 1,528 2,077 2,025 2,605 2,583 2,727 3,160 3,863
Goodwill
1,360 1,237 1,188 1,273 1,312 1,710 1,502 1,571 1,884 2,350
Intangible Assets
335 209 182 169 143 292 237 201 297 434
Noncurrent Deferred & Refundable Income Taxes
19 18 16 25 33 38 33 70 83 84
Other Noncurrent Operating Assets
130 346 136 610 537 565 811 885 897 995
Total Liabilities & Shareholders' Equity
3,189 3,086 2,938 3,515 3,440 4,090 3,946 4,368 4,831 5,803
Total Liabilities
1,718 1,576 1,540 2,069 1,928 2,523 2,474 2,511 2,785 3,440
Total Current Liabilities
798 718 655 776 774 923 841 955 1,079 1,264
Accounts Payable
534 560 416 444 452 497 580 638 707 821
Current Deferred Revenue
150 149 - - - - 242 301 349 424
Current Deferred & Payable Income Tax Liabilities
1.34 8.74 28 22 19 21 19 16 22 19
Total Noncurrent Liabilities
919 837 885 1,293 1,154 1,600 1,597 1,517 1,661 2,142
Long-Term Debt
691 588 649 627 497 935 921 850 973 1,348
Capital Lease Obligations
- - 0.00 454 412 427 73 77 79 83
Noncurrent Deferred & Payable Income Tax Liabilities
59 43 51 65 58 68 26 20 44 53
Noncurrent Employee Benefit Liabilities
38 36 50 66 71 46 24 22 16 14
Other Noncurrent Operating Liabilities
131 170 135 81 115 126 553 548 549 644
Total Equity & Noncontrolling Interests
1,471 2,999 1,399 1,447 1,512 1,567 1,472 1,857 2,045 2,363
Total Preferred & Common Equity
1,470 2,997 1,397 1,445 1,512 1,567 0.00 0.00 0.00 0.00
Total Common Equity
1,470 2,997 1,397 1,445 1,512 1,567 0.00 0.00 0.00 0.00
Noncontrolling Interest
0.60 2.38 1.32 1.23 0.63 0.39 1,472 1,857 2,045 2,363

Quarterly Balance Sheets for Stantec

No quarterly balance sheets for Stantec are available.


Annual Metrics And Ratios for Stantec

This table displays calculated financial ratios and metrics derived from Stantec's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - -
Revenue Growth
0.00% -99.34% 14,860.76% 17.15% 1.31% -3.75% 17.90% 13.57% 6.37% 14.55%
EBITDA Growth
0.00% -1,459.99% 107.98% 68.52% -35.65% 29.66% 9.63% 25.80% 2.48% 24.87%
EBIT Growth
0.00% -2,628.76% 104.90% 38.83% -19.74% 44.22% 0.48% 31.09% 4.31% 31.05%
NOPAT Growth
0.00% -2,479.39% 107.24% 45.91% -23.88% 10.12% 27.68% 14.95% 8.12% 51.09%
Net Income Growth
0.00% -20.62% -54.94% 331.34% -10.47% 17.11% 16.20% 31.34% 4.72% 39.27%
EPS Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth
0.00% 0.00% -99.92% -17.57% 2,734.05% -74.79% 290.64% 531.51% 6.33% 50.26%
Free Cash Flow Firm Growth
0.00% 0.00% 117.24% -157.49% 237.73% -209.48% 132.12% 241.93% -134.58% 5.66%
Invested Capital Growth
0.00% 9.58% -12.54% 26.83% -6.66% 26.63% 5.16% -3.78% 16.79% 19.24%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - -
Gross Margin
39.10% -8,486.36% 42.38% 42.09% 40.63% 42.86% 42.26% 77.70% 77.79% 79.44%
EBITDA Margin
6.67% -13,796.59% 7.36% 10.58% 6.72% 9.05% 8.42% 9.33% 8.98% 9.79%
Operating Margin
3.82% -14,254.92% 4.83% 6.01% 4.52% 6.77% 5.60% 5.67% 5.76% 7.60%
EBIT Margin
3.71% -14,270.83% 4.67% 5.53% 4.38% 6.57% 5.60% 6.46% 6.34% 7.25%
Profit (Net Income) Margin
3.04% 367.42% 1.11% 4.07% 3.60% 4.38% 4.32% 4.99% 4.92% 5.98%
Tax Burden Percent
72.18% -2.59% 27.67% 100.00% 107.54% 76.31% 100.00% 77.63% 77.69% 76.10%
Interest Burden Percent
113.64% 99.24% 85.65% 73.64% 76.38% 87.40% 77.14% 99.56% 99.87% 108.36%
Effective Tax Rate
27.82% 0.00% 0.00% 0.00% 0.00% 23.69% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
5.08% -115.44% 8.53% 11.76% 8.28% 8.33% 9.28% 10.60% 10.79% 13.80%
ROIC Less NNEP Spread (ROIC-NNEP)
8.60% -630.21% 36.23% -3.80% 2.11% 4.21% 3.41% 6.53% 5.24% 4.48%
Return on Net Nonoperating Assets (RNNOA)
1.52% 118.89% -6.95% -1.22% 0.79% 1.87% 1.93% 3.11% 2.08% 2.06%
Return on Equity (ROE)
6.60% 3.45% 1.58% 10.53% 9.07% 10.20% 11.21% 13.71% 12.87% 15.86%
Cash Return on Invested Capital (CROIC)
0.00% -124.59% 21.91% -11.90% 15.16% -15.17% 4.25% 14.45% -4.70% -3.76%
Operating Return on Assets (OROA)
3.71% -95.44% 4.87% 6.31% 4.69% 6.25% 5.72% 7.46% 7.03% 7.98%
Return on Assets (ROA)
3.05% 2.46% 1.15% 4.64% 3.86% 4.17% 4.42% 5.77% 5.46% 6.58%
Return on Common Equity (ROCE)
6.60% 3.45% 1.58% 10.52% 9.06% 10.20% 5.39% 0.00% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)
6.61% 2.57% 2.49% 10.37% 8.87% 10.03% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
88 -2,093 152 221 168 185 237 272 294 444
NOPAT Margin
2.76% -9,978.45% 4.83% 6.01% 4.52% 5.17% 5.60% 5.67% 5.76% 7.60%
Net Nonoperating Expense Percent (NNEP)
-3.52% 514.77% -27.71% 15.56% 6.17% 4.12% 5.87% 4.07% 5.55% 9.32%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 9.77% 9.50% 11.71%
Cost of Revenue to Revenue
62.08% 8,586.36% 58.91% 59.08% 60.59% 57.05% 59.11% 22.30% 22.21% 20.56%
SG&A Expenses to Revenue
31.14% 5,332.20% 33.58% 30.05% 28.47% 31.07% 30.46% 31.01% 31.09% 30.64%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
34.10% 5,768.56% 36.27% 34.91% 34.89% 36.08% 35.29% 72.03% 72.03% 71.84%
Earnings before Interest and Taxes (EBIT)
118 -2,994 147 203 163 236 237 310 324 424
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
213 -2,894 231 389 250 325 356 448 459 573
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 2.08 2.31 3.90 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 953.37 61.26 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.82 0.94 1.70 1.25 1.84 1.75 1.84
Price to Earnings (P/E)
0.00 0.00 0.00 20.11 26.03 38.86 28.93 36.79 35.65 30.79
Dividend Yield
1.97% 1.95% 2.69% 2.15% 1.98% 1.20% 1.52% 0.98% 0.85% 0.68%
Earnings Yield
0.00% 0.00% 0.00% 4.97% 3.84% 2.57% 3.46% 2.72% 2.81% 3.25%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 1.88 2.14 2.96 3.02 4.51 4.05 4.07
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 1.08 1.13 2.05 1.87 2.36 2.33 2.44
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 10.17 16.82 22.65 22.18 25.32 25.91 24.90
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 19.46 25.79 31.23 33.36 36.55 36.74 33.65
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 17.90 25.02 39.68 33.36 41.67 40.42 32.11
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 1,771.32 66.48 460.59 126.58 28.78 28.38 22.67
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 13.66 0.00 72.82 30.58 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.52 0.20 0.49 0.77 0.63 0.89 0.61 0.50 0.51 0.61
Long-Term Debt to Equity
0.47 0.20 0.46 0.75 0.60 0.87 0.61 0.50 0.51 0.61
Financial Leverage
0.18 -0.19 -0.19 0.32 0.37 0.45 0.57 0.48 0.40 0.46
Leverage Ratio
2.17 1.40 1.37 2.27 2.35 2.45 2.54 2.50 2.36 2.41
Compound Leverage Factor
2.46 1.39 1.17 1.67 1.80 2.14 1.96 2.49 2.35 2.61
Debt to Total Capital
34.05% 16.39% 32.85% 43.58% 38.48% 47.20% 37.98% 33.29% 33.96% 37.71%
Short-Term Debt to Total Capital
3.07% 0.00% 1.71% 1.41% 1.49% 1.34% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
30.98% 16.39% 31.14% 42.17% 37.00% 45.86% 37.98% 33.29% 33.96% 37.71%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.03% 0.07% 0.06% 0.05% 0.03% 0.01% 62.02% 66.71% 66.04% 62.29%
Common Equity to Total Capital
65.92% 83.55% 67.09% 56.37% 61.49% 52.78% 0.00% 0.00% 0.00% 0.00%
Debt to EBITDA
3.57 -0.20 2.96 2.87 3.78 4.32 2.91 2.07 2.29 2.50
Net Debt to EBITDA
2.77 -0.13 2.35 2.43 2.87 3.85 2.60 1.47 1.95 1.99
Long-Term Debt to EBITDA
3.25 -0.20 2.81 2.78 3.63 4.19 2.91 2.07 2.29 2.50
Debt to NOPAT
8.63 -0.28 4.52 5.05 5.62 7.56 4.37 3.41 3.58 3.22
Net Debt to NOPAT
6.70 -0.18 3.57 4.27 4.27 6.74 3.91 2.42 3.04 2.57
Long-Term Debt to NOPAT
7.85 -0.28 4.28 4.89 5.40 7.34 4.37 3.41 3.58 3.22
Altman Z-Score
0.00 0.00 0.00 2.54 2.79 2.91 2.65 3.65 3.38 3.29
Noncontrolling Interest Sharing Ratio
0.04% 0.07% 0.08% 0.09% 0.06% 0.03% 51.89% 100.00% 100.00% 100.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.48 1.78 1.83 1.57 1.59 1.41 1.75 1.80 1.64 1.61
Quick Ratio
0.95 1.64 1.26 1.10 1.11 0.92 1.56 1.62 1.47 1.42
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -2,259 389 -224 308 -338 108 371 -128 -121
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 -109.77 18.52 -4.17 7.99 -11.38 2.00 5.26 -1.77 -1.63
Operating Cash Flow to Interest Expense
0.00 163.53 0.13 0.04 1.64 0.54 1.15 5.59 5.78 8.46
Operating Cash Flow Less CapEx to Interest Expense
0.00 165.81 0.13 0.04 1.64 0.54 1.15 5.59 5.78 8.46
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
1.00 0.01 1.04 1.14 1.07 0.95 1.02 1.16 1.11 1.10
Accounts Receivable Turnover
5.32 0.03 3.87 5.77 6.16 5.86 4.66 3.92 3.78 3.99
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
20.04 0.00 0.00 16.99 18.22 19.32 0.00 0.00 0.00 0.00
Accounts Payable Turnover
3.71 3.29 3.79 5.05 5.04 4.31 4.74 1.76 1.69 1.57
Days Sales Outstanding (DSO)
68.65 13,729.23 94.29 63.21 59.22 62.26 78.28 93.01 96.51 91.43
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
98.48 110.87 96.30 72.23 72.43 84.61 77.07 207.63 216.48 231.84
Cash Conversion Cycle (CCC)
-29.83 13,618.37 -2.01 -9.02 -13.22 -22.35 1.21 -114.62 -119.98 -140.41
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
1,730 1,896 1,658 2,103 1,963 2,486 2,614 2,516 2,938 3,503
Invested Capital Turnover
1.84 0.01 1.77 1.96 1.83 1.61 1.66 1.87 1.87 1.82
Increase / (Decrease) in Invested Capital
0.00 166 -238 445 -140 523 128 -99 422 565
Enterprise Value (EV)
0.00 0.00 0.00 3,959 4,211 7,354 7,895 11,336 11,887 14,267
Market Capitalization
0.00 0.00 0.00 3,012 3,491 6,104 5,280 8,820 8,949 10,763
Book Value per Share
$1,205,118,530.33 $3,525,676,758.82 $12.49 $12.92 $13.59 $14.11 $0.00 $0.00 $0.00 $0.00
Tangible Book Value per Share
($184,150,065.57) $1,825,057,303.53 $0.25 $0.03 $0.51 ($3.92) ($17.70) ($15.99) ($19.11) ($24.40)
Total Capital
2,230 3,587 2,083 2,564 2,459 2,968 2,724 2,783 3,097 3,794
Total Debt
759 588 684 1,117 946 1,401 1,035 926 1,052 1,430
Total Long-Term Debt
691 588 649 1,081 910 1,361 1,035 926 1,052 1,430
Net Debt
589 382 542 945 719 1,249 925 659 893 1,140
Capital Expenditures (CapEx)
0.00 -47 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
284 364 443 306 263 268 503 499 533 481
Debt-free Net Working Capital (DFNWC)
448 560 579 478 490 420 612 766 691 771
Net Working Capital (NWC)
379 560 544 442 453 380 612 766 691 771
Net Nonoperating Expense (NNE)
-9.13 -2,171 117 71 34 28 54 32 43 95
Net Nonoperating Obligations (NNO)
260 -1,103 260 657 451 919 925 659 893 1,140
Total Depreciation and Amortization (D&A)
94 99 84 186 87 89 119 138 135 149
Debt-free, Cash-free Net Working Capital to Revenue
8.91% 1,734.09% 14.13% 8.32% 7.05% 7.47% 11.89% 10.39% 10.43% 8.22%
Debt-free Net Working Capital to Revenue
14.03% 2,671.21% 18.45% 13.01% 13.14% 11.70% 14.48% 15.95% 13.54% 13.18%
Net Working Capital to Revenue
11.89% 2,671.21% 17.32% 12.03% 12.16% 10.59% 14.48% 15.95% 13.54% 13.18%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $1.74 $0.00 $1.80 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
0.00 1.00 0.00 111.21M 111.01M 111.33M 110.81M 114.07M 114.07M 114.07M
Adjusted Diluted Earnings per Share
$0.00 $0.85 $0.00 $1.74 $0.00 $1.80 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 0.00 111.21M 111.01M 111.33M 110.81M 114.07M 114.07M 114.07M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $1.74 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 111.21M 111.01M 111.33M 110.81M 114.07M 228.13M 228.13M
Normalized Net Operating Profit after Tax (NOPAT)
88 -2,093 106 156 161 200 166 191 223 314
Normalized NOPAT Margin
2.76% -9,978.45% 3.38% 4.24% 4.32% 5.58% 3.92% 3.97% 4.36% 5.37%
Pre Tax Income Margin
4.22% -14,162.12% 4.00% 4.07% 3.35% 5.74% 4.32% 6.43% 6.33% 7.85%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
5.56 -145.46 6.97 3.79 4.23 7.94 4.37 4.40 4.46 5.70
NOPAT to Interest Expense
4.13 -101.71 7.21 4.12 4.36 6.25 4.37 3.86 4.06 5.97
EBIT Less CapEx to Interest Expense
5.56 -143.19 6.97 3.79 4.23 7.94 4.37 4.40 4.46 5.70
NOPAT Less CapEx to Interest Expense
4.13 -99.44 7.21 4.12 4.36 6.25 4.37 3.86 4.06 5.97
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
-0.61% -57.22% 0.00% 0.00% 0.00% 0.00% 0.00% 26.82% 26.00% 21.07%
Augmented Payout Ratio
-0.61% -57.22% 0.00% 0.00% 0.00% 0.00% 0.00% 26.82% 26.00% 21.07%

Quarterly Metrics And Ratios for Stantec

No quarterly metrics and ratios for Stantec are available.



Financials Breakdown Chart

Frequently Asked Questions About Stantec's Financials

When does Stantec's financial year end?

According to the most recent income statement we have on file, Stantec's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has Stantec's net income changed over the last 9 years?

Stantec's net income appears to be on an upward trend, with a most recent value of $349.62 million in 2025, rising from $97.11 million in 2016. The previous period was $251.04 million in 2024. Check out Stantec's forecast to explore projected trends and price targets.

What is Stantec's operating income?
Stantec's total operating income in 2025 was $444.36 million, based on the following breakdown:
  • Total Gross Profit: $4.65 billion
  • Total Operating Expenses: $4.20 billion
How has Stantec's revenue changed over the last 9 years?

Over the last 9 years, Stantec's total revenue changed from $3.19 billion in 2016 to $5.85 billion in 2025, a change of 83.4%.

How much debt does Stantec have?

Stantec's total liabilities were at $3.44 billion at the end of 2025, a 23.5% increase from 2024, and a 100.3% increase since 2016.

How much cash does Stantec have?

In the past 9 years, Stantec's cash and equivalents has ranged from $109.59 million in 2022 to $290.33 million in 2025, and is currently $290.33 million as of their latest financial filing in 2025.

How has Stantec's book value per share changed over the last 9 years?

Over the last 9 years, Stantec's book value per share changed from 1,205,118,530.33 in 2016 to 0.00 in 2025, a change of -100.0%.



Financial statements for NYSE:STN last updated on 2/26/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners